Results 81 to 90 of about 1,191,599 (308)

Transportation network companies as cost reduction strategies for paratransit [PDF]

, 2018
Paratransit service is an auxiliary type of public transportation provided for people with disabilities and older adults. Federal ADA regulations require all transit agencies receiving federal funding to provide paratransit service, but the per trip cost
Minot, Aysha Lauren Elysabeth
core   +1 more source

Enzymatic and microbial routes to bioplastics: The green chemistry frontier of biopolymers

FEBS Open Bio, EarlyView.
Microbial biosynthesis and engineered enzyme platforms are expanding the design space of polyhydroxyalkanoate bioplastics. By combining fermentation, PHA synthase engineering and cell‐free modular systems, tailored biodegradable polymers can be produced with tunable properties, supporting more sustainable materials and future circular bioeconomy ...
Giovanni Gallo, Emma Piccoli, Luca Bombardi, Martina Aulitto, Salvatore Fusco   +4 more
wiley   +1 more source

FORMATION AND WAYS TO OPTIMIZE TRANSPORTATION COSTS OF A MANUFACTURING ENTERPRISE

International Journal of Advanced Studies
The article examines the patterns of changes in transport costs of a company providing transport and logistics services. The transport company "M" was chosen as the object of the study.
Tatyana V. Konovalova, Alexander N. Dombrovsky, Sofiya L. Nadiryan, Sofiya V. Kotsurba   +3 more
doaj   +1 more source

Behaviors and housing inertia are key factors in determining the consequences of a shock in transportation costs [PDF]

This paper investigates the consequences of a sudden increase in transportation costs when households behaviors and buildings inertia are accounted for.
François Gusdorf, Stéphane Hallegatte
core  

Re‐Awakening Public Attention to the Silent Pandemic of Cancer Among Older Adults in Low‐ and Middle‐Income Countries

Aging and Cancer, EarlyView.
ABSTRACT As global populations age, cancer is increasingly becoming a leading cause of morbidity and mortality among older adults, particularly in low‐ and middle‐income countries (LMICs). Despite accounting for the majority of new cancer cases and deaths, older individuals remain underrepresented in cancer research, clinical guidelines, and health ...
Ibrahim Bidemi Abdullateef, Sunkanmi Folorunsho, Abdulazeez Opeyemi Abdulganiyu   +2 more
wiley   +1 more source

The Nonlinear Generalized Transportation Problem with convex costs

Croatian Operational Research Review, 2015
We investigate the Nonlinear Generalized Transportation Problem (NGTP), where the transportation costs and the costs that depend on the amount of good delivered to the destination points are strictly convex functions.
Marcin Anholcer
doaj   +1 more source

Transport costs, distance, and time : evidence from the Japanese Census of Logistics [PDF]

Geographic distance is a standard proxy for transport costs under the simple assumption that freight fees increase monotonically over space. Using the Japanese Census of Logistics, this paper examines the extent to which transport distance and time ...
Tanaka, Kiyoyasu
core  

An Optimization Model for Single-Warehouse Multi-Agents Distribution Network Problems under Varying of Transportation Facilities: A Case Study [PDF]

, 2008
The transportation cost of goods is the highest day-to-day operational cost associated with the food industry sector. A company may be able to reduce logistics cost and simultaneously improve service level by optimizing
Fauziati, Alfin Nuriya, Hisjam, Muh., Sutopo, Wahyudi, Yuniaristanto,   +3 more
core  

Fluid and Neuroimaging Biomarkers in Microgliopathy Colony‐Stimulating Factor‐1 Receptor‐Related Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela, Madison Reeves, Karen Jansen‐West, Judith Dunmore, Yuping Song, Audrey Strongosky, Sunil Gandhi, Gilana Pikover, Matt Blurton‐Jones, Robert C. Spitale, Erik H. Middlebrooks, Leonard Petrucelli, Mercedes Prudencio, Zbigniew K. Wszolek   +13 more
wiley   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source